Form 4: Clorox CEO Rendle's Stock Transactions Post-Vesting

Clorox CEO Linda Rendle reported the settlement of 2022 performance unit grants, acquiring 43,370 shares, and subsequent tax-related dispositions of 9,462 shares, resulting in a beneficial ownership of 201,990 shares.

Summary

• Linda J Rendle, Chief Executive Officer and Director of The Clorox Co, reported transactions involving common stock.
• On October 3, 2025, 43,370 shares of common stock were acquired at a price of $122.25 per share, stemming from the settlement of a 2022 Performance Unit Grant that vested on the same date.
• The reporting person elected to defer the settlement of these performance units pursuant to the 2005 Stock Incentive Plan.
• Following this acquisition, beneficial ownership stood at 211,452 shares.
• Also on October 3, 2025, 1,022 shares were disposed of at $122.25 per share to satisfy tax obligations related to the vesting of performance stock units.
• An additional 8,440 shares were disposed of at $122.25 per share to satisfy tax obligations related to the vesting of restricted stock.
• After all reported transactions, Linda J Rendle's direct beneficial ownership of common stock is 201,990 shares.
• The reported beneficial ownership includes 4,274 shares acquired through a dividend reinvestment feature of the Company's Stock Incentive Plan.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as the vesting of performance units indicates the achievement of executive performance targets. The tax-related dispositions are routine and do not reflect a negative sentiment.

Positives

• The vesting of 2022 Performance Unit Grants indicates that performance targets set for the CEO were met, aligning executive compensation with company performance.
• The deferral of the settlement of performance units suggests a long-term commitment to the company's stock by the CEO.

Negatives

• The disposition of 9,462 shares was solely for tax withholding purposes, which is a standard practice and not indicative of a negative outlook on the stock.

Related Party Transactions

• The reported transactions involve the settlement of executive compensation awards (performance units and restricted stock) granted by The Clorox Co to its CEO, Linda J Rendle, which are considered related party transactions in the context of executive compensation.

Stakeholder Impact

• Shareholders: The transactions are routine executive compensation events and do not directly impact the company's operational performance or financial health. They reflect the execution of existing compensation plans.
• Employees: No direct impact on general employees is indicated by this filing.
• Management: The vesting and deferral of performance units reinforce the compensation structure for the CEO, aligning her interests with long-term company performance.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation events, specifically the vesting of performance units and restricted stock, followed by tax-related share dispositions. Such transactions are standard and do not provide new fundamental information about the company's operational performance, strategic direction, or future prospects that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining existing positions based on broader company fundamentals rather than these specific insider transactions.

Keywords

Clorox, CLX, Linda Rendle, CEO, Insider Transaction, Form 4, Stock Vesting, Performance Units, Restricted Stock, Executive Compensation